Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


New report debunks idea of industry piggybacking on NIH

This article was originally published in Scrip

Executive Summary

In a new report, Manhattan Institute for Public Policy senior fellow Dr Benjamin Zycher, along with Joseph DiMasi and Christopher-Paul Milne, researchers at the Boston-based Tufts Center for the Study of Drug Development, attempt to answer sceptics of private industry who assert that drug companies get a “free ride” on government research, and that publiclyfunded medical research – not the industry itself – is by far the major source of innovative drugs.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts